Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Novel adjuvant Alum-TLR7 significantly potentiates immune response to glycoconjugate vaccines.

Buonsanti C, Balocchi C, Harfouche C, Corrente F, Galli Stampino L, Mancini F, Tontini M, Malyala P, Bufali S, Baudner B, De Gregorio E, Valiante NM, O'Hagan DT, Rappuoli R, D'Oro U.

Sci Rep. 2016 Jul 21;6:29063. doi: 10.1038/srep29063.

2.

Small molecule Toll-like receptor 7 agonists localize to the MHC class II loading compartment of human plasmacytoid dendritic cells.

Russo C, Cornella-Taracido I, Galli-Stampino L, Jain R, Harrington E, Isome Y, Tavarini S, Sammicheli C, Nuti S, Mbow ML, Valiante NM, Tallarico J, De Gregorio E, Soldaini E.

Blood. 2011 May 26;117(21):5683-91. doi: 10.1182/blood-2010-12-328138. Epub 2011 Apr 12.

PMID:
21487111
3.

Association of hepatitis C virus envelope proteins with exosomes.

Masciopinto F, Giovani C, Campagnoli S, Galli-Stampino L, Colombatto P, Brunetto M, Yen TS, Houghton M, Pileri P, Abrignani S.

Eur J Immunol. 2004 Oct;34(10):2834-42.

4.

Molecular analysis of V(H)I+ B lymphocytes in hepatitis C patients.

Galli-Stampino L, Pasqualini A, Pozzato G, Bonino F, Filipponi F, Mosca M, Masciopinto F, Abrignani S, Uematsu Y.

Dig Liver Dis. 2003 Nov;35(11):788-94.

PMID:
14674669
5.

Innate immune responses support adaptive immunity: NKT cells induce B cell activation.

Galli G, Nuti S, Tavarini S, Galli-Stampino L, De Lalla C, Casorati G, Dellabona P, Abrignani S.

Vaccine. 2003 Jun 1;21 Suppl 2:S48-54. Review.

PMID:
12763683
6.

CD1d-restricted help to B cells by human invariant natural killer T lymphocytes.

Galli G, Nuti S, Tavarini S, Galli-Stampino L, De Lalla C, Casorati G, Dellabona P, Abrignani S.

J Exp Med. 2003 Apr 21;197(8):1051-7. Epub 2003 Apr 14.

7.

Different profile of CD8+ effector T cells induced in Der p 1-allergic and naïve mice by DNA vaccination.

Draghi M, Jarman ER, Grifantini R, Galli-Stampino L, Lamb JR, Valiante NM, Grandi G.

Eur J Immunol. 2002 Dec;32(12):3720-8.

8.

Expression of human CD81 in transgenic mice does not confer susceptibility to hepatitis C virus infection.

Masciopinto F, Freer G, Burgio VL, Levy S, Galli-Stampino L, Bendinelli M, Houghton M, Abrignani S, Uematsu Y.

Virology. 2002 Dec 20;304(2):187-96.

9.

T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity.

Galli-Stampino L, Meinjohanns E, Frische K, Meldal M, Jensen T, Werdelin O, Mouritsen S.

Cancer Res. 1997 Aug 1;57(15):3214-22.

10.

Carbohydrate and peptide specificity of MHC class II-restricted T cell hybridomas raised against an O-glycosylated self peptide.

Jensen T, Hansen P, Galli-Stampino L, Mouritsen S, Frische K, Meinjohanns E, Meldal M, Werdelin O.

J Immunol. 1997 Apr 15;158(8):3769-78.

PMID:
9103442
11.

Multiple column synthesis of a library of T-cell stimulating Tn-antigenic glycopeptide analogues for the molecular characterization of T-cell-glycan specificity.

Frische K, Meldal M, Werdelin O, Mouritsen S, Jensen T, Galli-Stampino L, Bock K.

J Pept Sci. 1996 Jul-Aug;2(4):212-22.

PMID:
9231328
12.

T cell recognition of Tn-glycosylated peptide antigens.

Jensen T, Galli-Stampino L, Mouritsen S, Frische K, Peters S, Meldal M, Werdelin O.

Eur J Immunol. 1996 Jun;26(6):1342-9.

PMID:
8647215

Supplemental Content

Loading ...
Support Center